Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Equity (2016 - 2025)

Historic Return on Equity for Corcept Therapeutics (CORT) over the last 11 years, with Q3 2025 value amounting to 0.17%.

  • Corcept Therapeutics' Return on Equity fell 600.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.24% for FY2024, which is 300.0% up from last year.
  • Per Corcept Therapeutics' latest filing, its Return on Equity stood at 0.17% for Q3 2025, which was down 600.0% from 0.2% recorded in Q2 2025.
  • Corcept Therapeutics' 5-year Return on Equity high stood at 0.29% for Q1 2022, and its period low was 0.17% during Q3 2025.
  • For the 5-year period, Corcept Therapeutics' Return on Equity averaged around 0.22%, with its median value being 0.21% (2022).
  • As far as peak fluctuations go, Corcept Therapeutics' Return on Equity skyrocketed by 900bps in 2022, and later plummeted by -1000bps in 2023.
  • Over the past 5 years, Corcept Therapeutics' Return on Equity (Quarter) stood at 0.25% in 2021, then decreased by -15bps to 0.21% in 2022, then grew by 5bps to 0.22% in 2023, then fell by -2bps to 0.21% in 2024, then dropped by -22bps to 0.17% in 2025.
  • Its Return on Equity was 0.17% in Q3 2025, compared to 0.2% in Q2 2025 and 0.2% in Q1 2025.